Up-to-date epidemiological data and better treatment for Kaposi's sarcoma

Transplantation

Volumn 80, Issue 12, 2005, Pages 1656-1657

  Alamartine, Eric ^a  

^a HÔPITAL NORD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; ALPHA INTERFERON; ANTIRETROVIRUS AGENT; CIDOFOVIR; CYCLOSPORIN; DAUNORUBICIN; DOXORUBICIN; FOSCARNET SODIUM; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; PACLITAXEL; RAPAMYCIN; RITUXIMAB;

ACUTE GRAFT REJECTION; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; KIDNEY GRAFT REJECTION; NOTE; PREVALENCE; PRIORITY JOURNAL;

DATABASES, FACTUAL; FRANCE; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HUMANS; ITALY; PREVALENCE; SARCOMA, KAPOSI;

EID: 30144442299     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000187867.53355.fe     Document Type: Note

References (6)

1. Serraino D, Piselli P, Angeletti C, et al. Risk of Kaposi's sarcoma and of other cancers in Italian renal transplant patients. Br J Cancer 2005; 92: 572.
2. Serraino D, Angeletti C, Carrieri MP, et al. Kaposi's sarcoma in transplant and HIV-infected patients: an epidemiologic study in Italy and France. Transplantation 2005; 80: XXXX.
3. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant 2005; 4: 905.
4. Dezube BJ, Pantanowitz L, Aboulafia DM. Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment. AIDS Read 2004; 14: 236.
5. Campistol J, Gutierez-Dalmas A, Torregrosa JV, et al. Conversion to sirolimus: a successful treatment for post-transplantation kaposi's sarcoma. Transplantation 2004; 77: 760.
6. Stallone G, Schena A, Infante B, et al. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med 2005; 352: 1317.